Is infection a major risk factor for preeclampsia?

Area of Science:

• Obstetrics and Gynecology
• Maternal-Fetal Medicine
• Infectious Diseases in Pregnancy

Background:

• Preeclampsia poses significant risks to maternal and fetal health.
• Identifying high-risk pregnancies early is crucial for effective intervention.
• Subclinical infections are increasingly recognized as potential contributors to pregnancy complications.

Purpose of the Study:

• To evaluate the impact of a biopsychosocial risk model on identifying and managing high-risk pregnancies.
• To assess the effectiveness of nutritional supplementation and infection treatment in reducing adverse pregnancy outcomes.
• To explore the potential link between asymptomatic infections and preeclampsia development.

Main Methods:

• A population-based program involving 15,354 pregnant women in Colombia.
• Application of a biopsychosocial risk model for early identification of high-risk individuals.
• Intervention group received linoleic acid, calcium, and antibiotics for identified infections.

Main Results:

• A significant reduction in preeclampsia incidence (52.5%) compared to the previous five years.
• Marked decreases in low birthweight (53%) and preterm delivery (64.7%).
• High prevalence of bacteriuria (11.5%) and vaginal infections (14.0%) identified and treated.

Conclusions:

• Early risk factor identification, nutritional support, and infection treatment can dramatically reduce adverse pregnancy outcomes.
• The study suggests a potential role for chronic subclinical infections in preeclampsia pathogenesis.
• Further clinical trials are warranted to confirm the relationship between infection, inflammation, and preeclampsia.